Skip to main content
. 2021 Jul 22;12:713960. doi: 10.3389/fimmu.2021.713960

Figure 2.

Figure 2

In vivo biodistribution analysis of BCCY-1. (A) In vivo imaging of mice and (B) ex vivo imaging of major organs at indicated hours after TAMRA-BCCY-1 treatment. Average radiant efficiency ([p/s/cm2/sr]/[μW/cm2]) was quantified at indicated time points. (C, D) The biodistribution of BCCY-1 in peripheral blood cells (lymphocytes, monocytes and granulocytes) was analyzed by flow cytometry at indicated hours. The percentage of TAMRA positive cells in the indicated cell population was quantified.